UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~WASHINGTON~~Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

May 4 13, 2016

Date of Report (Date of earliest event reported)

inVentiv Health, Inc.

(Exact name of registrant as specified in its charter)

Delaware


Delaware	000-30318	52-2181734
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

1 Van De Graaff Drive
Burlington, Massachusetts		01803
(Address of principal executive offices)		(Zip Code)

(State or other jurisdiction of incorporation)

000-30318		52-2181734
(Commission File Number)		(IRS Employer Identification No.)
1 Van De Graaff Drive
Burlington, Massachusetts		01803
(Address of principal executive offices)		(Zip Code)

(800) 416-0555

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 82.0102 ~~Other~~Results ~~Events~~of Operations and Financial Condition.

As previously disclosed on a Current Report on Form 8-K filed with the Securities Exchange Commission on May 4, 2016, inVentiv Health, Inc. (the “Company”) will ~~hold~~discuss the Company’s financial results for the first quarter of 2016 during a conference call at 2:~~00PM~~00 p.m. Eastern Time on May 16, 2016. During this conference call, ~~during~~the ~~which~~Company itintends ~~will~~to ~~discuss~~use and reference the ~~Company’s~~presentation ~~financial~~furnished ~~results~~herewith. ~~for~~A copy of the ~~first~~presentation ~~quarter~~is offurnished ~~2016~~as Exhibit 99.1 and is incorporated herein by reference.

The ~~U.S.~~information furnished ~~dial~~on this Form 8-inK shall not be deemed “filed” for purposes of Section 18 of the ~~call~~Securities isExchange ~~(877)~~Act ~~498-6434~~of ~~((929)~~1934, ~~387-3953~~as ~~for~~amended ~~non-U.S.~~(the ~~callers~~“Exchange Act”), ~~and the~~or ~~passcode~~otherwise issubject ~~5306917.~~to Athe ~~replay~~liabilities of ~~the~~that ~~conference~~section, ~~call~~nor ~~will~~shall it be ~~available~~deemed ~~until~~incorporated ~~May~~by ~~23,~~reference ~~2016~~into byany ~~dialing~~filing ~~(855)~~under ~~859-2056~~the ~~((404)~~Securities ~~537-3406~~Act ~~for~~of ~~non-U.S.~~1933, ~~callers)~~as ~~and~~amended, or the ~~passcode~~Exchange isAct, ~~5306917~~regardless of any general incorporation language in such filing.

~~The~~Item ~~information~~9.01 ~~furnished~~Financial onStatements ~~this~~and Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filingExhibits.

~~SIGNATURES~~(d) Exhibits

~~Pursuant~~99.1 toInvestor ~~the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized~~Presentation.

~~INVENTIV~~SIGNATURES ~~HEALTH, INC. By: /s/ Jonathan E. Bicknell Name: Jonathan E. Bicknell Title: Chief Financial Officer~~

~~Date:~~Pursuant ~~May~~to 4the requirements of the Securities Exchange Act of 1934, ~~2016~~the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

3INVENTIV HEALTH, INC. By: /s/ Jonathan E. Bicknell Name: Jonathan E. Bicknell Title: Chief Financial Officer

Date: May 13, 2016

Filing Compare · INVENTIV HEALTH INC